NexturnBioscience Co. Ltd (089140) — Capital Reinvestment Ratio
NexturnBioscience Co. Ltd (089140) has a Capital Reinvestment Ratio of 0.06x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩4.51 Billion) in capital expenditures (₩286.65 Million). See NexturnBioscience Co. Ltd (089140) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
NexturnBioscience Co. Ltd Capital Reinvestment Ratio (2007–2021)
This chart tracks NexturnBioscience Co. Ltd's Capital Reinvestment Ratio across 12 annual periods. Check NexturnBioscience Co. Ltd (089140) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for NexturnBioscience Co. Ltd (2007–2021)
Year-by-year Capital Reinvestment Ratio for NexturnBioscience Co. Ltd from 2007 to 2021. For live market cap and broader valuation context, see 089140 market cap overview.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.13x | ₩3.66 Billion | ₩467.60 Million | ▼ -97.5% |
| 2020 | 5.15x | ₩235.94 Million | ₩1.21 Billion | ▼ -23.4% |
| 2019 | 6.72x | ₩2.74 Billion | ₩18.38 Billion | ▲ +32348.4% |
| 2018 | 0.02x | ₩9.63 Billion | ₩199.42 Million | ▼ -87.9% |
| 2017 | 0.17x | ₩5.08 Billion | ₩870.45 Million | ▲ +242.6% |
| 2016 | 0.05x | ₩17.88 Billion | ₩893.46 Million | ▼ -89.4% |
| 2015 | 0.47x | ₩1.92 Billion | ₩906.54 Million | ▲ +34050.2% |
| 2014 | 0.00x | ₩6.48 Billion | ₩8.97 Million | ▼ -100.0% |
| 2010 | 5.15x | ₩235.94 Million | ₩1.21 Billion | ▲ +7445.3% |
| 2009 | 0.07x | ₩998.03 Million | ₩68.11 Million | ▼ -67.3% |
| 2008 | 0.21x | ₩945.34 Million | ₩197.16 Million | ▼ -88.1% |
| 2007 | 1.75x | ₩2.26 Billion | ₩3.97 Billion | — |